2.7.7.23	analysis	quick and sensitive enzyme detection assay based on the diphosphatase-coupled colorimetric method with malachite green, and assay for glucosamine-1-phosphate N-acetyltransferase activity of the bifunctional enzyme, both applicable in microtitter plates	-, 718708	
2.7.7.23	drug development	N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) is an attractive target for the development of antimicrobial agents	741100	
2.7.7.23	drug development	prokaryotic/microbial sugar nucleotidyl transferases are targets for design of selective inhibitors due to their different metal mechanisms compared to eukaryotes	740866	
2.7.7.23	drug development	the enzyme GlmU is a target for development of antibacterial drugs	720042	
2.7.7.23	drug development	the enzyme is a potential drug target	737391	
2.7.7.23	drug development	the enzyme is a target for drugs treating the witches broom disease caused by Moniliophthora perniciosa in Theobroma cacao	722022	
2.7.7.23	drug development	the identification of a selective inhibitory allosteric binding site in the parasite enzyme and the fact that the human and trypanosome enzymes both display a strictly ordered bi-bi mechanism, but with the order of substrate binding reversed, makes the enzyme a good target for drug development	737319	
2.7.7.23	medicine	GlmUMtb is a strong candidate for intervention measures against established tuberculosis infections	-, 737150	
2.7.7.23	medicine	potential target for antibacterial agents	643073, 643076	
2.7.7.23	synthesis	biosynthesis of UDP-N-acetyl-alpha-D-glucosamine. As glycosylation is the most important modification for activating peptide drugs, the activated form of N-acetyl-alpha-D-glucosamine is thought to be important for future development of effective drugs	-, 725308